Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibioticsCRITICAL CAREIF9.32021-02-115OAAI
Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibodyANNALS OF ONCOLOGYIF65.42017-11-0146OAAI
Aerosolized tobramycin for Pseudomonas aeruginosa ventilator-associated pneumonia in patients with acute respiratory distress syndromePULMONARY PHARMACOLOGY & THERAPEUTICSIF2.82017-08-018PREAI
Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studiestherapeutic advances in musculoskeletal diseaseIF32017-05-3017OAAI
Immunomodulatory Effect of Linezolid on Methicillin-Resistant Staphylococcus aureus Supernatant-Induced MUC5AC Overexpression in Human Airway Epithelial CellsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52014-07-017OAAI
Predictors of the pathogenicity of methicillin-resistant Staphylococcus aureus nosocomial pneumoniaRESPIROLOGYIF6.32014-04-0812PREAI
Azithromycin Attenuates Lung Inflammation in a Mouse Model of Ventilator-Associated Pneumonia by Multidrug-Resistant Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-08-0136OA
In Vivo Efficacy of Daptomycin against Methicillin-Resistant Staphylococcus aureus in a Mouse Model of Hematogenous Pulmonary InfectionANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-06-0115OAAI
Macrolides Inhibit Fusobacterium nucleatum-Induced MUC5AC Production in Human Airway Epithelial CellsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52013-04-0125OAAI